NCT07087327: A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
- State
- Under way
- Phase
- Phase 3
- People
- 180 planned
- Started
- 16 Sep 2025
- Primary completion
- Aug 2027
- Arms
- EB-1020 (QD XR Capsules) low dose
- Results
- None posted
- 28 Jul 2025: Trial registered
- 16 Sep 2025: Trial started